Other Events ·
The U.S. Bankruptcy Court for the Southern District of Texas confirmed Inotiv, Inc.'s amended joint prepackaged…
NOTVInotiv, Inc.
The U.S. Bankruptcy Court for the Southern District of Texas confirmed Inotiv, Inc.'s amended joint prepackaged Chapter 11 plan of reorganization on July 14, 2026. Under the plan, all 35,172,908 outstanding common shares will be canceled without any distribution to existing equity holders. The reorganized company intends to issue 5,100,000 new equity interests to holders of prepetition loans, secured notes, and convertible notes, plus warrants for an additional 630,337 new equity interests. Inotiv expects to emerge from bankruptcy as a private company. Inotiv, Inc. is a contract research organization providing nonclinical and analytical drug discovery and development services.